CMI Media Group’s Sports Marketing COE offers clients an innovative approach for reaching healthcare audiences in a space where they are likely to engage with brand messaging.
Lexeo Therapeutics’ investigational gene therapy reduces left ventricular volume and wall thickness in patients with Friedreich’s ataxia, according to a small study.
Following a disappointing IPO and the loss of Moderna’s gene editing contract, Metagenomi’s Chief Scientific Officer Luis Borges is departing the biotech.
Two-thirds of rare disease patients and caregivers from four countries report that the rare disease diagnosis took up to five years, while more than half of patient report being misdiagnosed at least once.
Despite recent concerns about suicidality and other neuropsychiatric issues, a recent study has found that Novo Nordisk’s Ozempic (semaglutide) is associated with lower risks of dementia, cognitive deficit and nicotine misuse.
In a political climate where discourse is often marked by division, there remain crucial issues that bridge partisan divides. The vital importance of treating children living with rare diseases is certainly one such cause.